当前位置:首页 - 行情中心 - 海森药业(001367) - 财务分析 - 利润表

海森药业

(001367)

  

流通市值:8.70亿  总市值:34.15亿
流通股本:3870.89万   总股本:1.52亿

利润表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、营业总收入118,478,458.16471,510,162.35320,044,589.93210,636,845.09
营业收入118,478,458.16471,510,162.35320,044,589.93210,636,845.09
二、营业总成本83,568,452.19333,026,439.58220,992,411.05145,296,234.7
营业成本66,096,444.72275,963,542.65187,645,243.67124,355,922.08
税金及附加1,014,074.354,358,439.453,346,394.482,253,160.59
销售费用2,561,780.5612,350,194.598,665,871.186,004,616.21
管理费用7,009,664.430,708,432.1118,198,366.5811,978,247.96
研发费用9,441,180.9627,779,529.0217,831,319.5511,588,314.81
财务费用-2,554,692.8-18,133,698.24-14,694,784.41-10,884,026.95
其中:利息费用84,933373,719.12279,121.44184,523.76
其中:利息收入1,918,551.5115,413,428.7513,284,0839,173,311.72
加:投资收益213,663.343,000,531.5174,271.23-
资产减值损失(新)-13,758.75-3,537,464.09-592,848.05-545,506.23
信用减值损失(新)45,086.1-101,545.95799,755.32425,213.87
其他收益657,757.394,200,666.712,196,462.592,152,303.34
营业利润平衡项目0000
四、营业利润35,812,754.05142,045,910.94101,629,819.9767,372,621.37
加:营业外收入501,168.491,228,509.6463,399.6462,601.01
减:营业外支出125,015.551,488,981.641,435,725.78434,650.99
利润总额平衡项目0000
五、利润总额36,188,906.99141,785,438.94100,257,493.8367,000,571.39
减:所得税费用4,976,725.419,227,707.2913,307,355.258,960,123.44
六、净利润31,212,181.59122,557,731.6586,950,138.5858,040,447.95
持续经营净利润31,212,181.59122,557,731.6586,950,138.5858,040,447.95
归属于母公司股东的净利润31,212,181.59122,557,731.6586,950,138.5858,040,447.95
(一)基本每股收益0.311.220.860.58
(二)稀释每股收益0.31.210.860.58
九、综合收益总额31,212,181.59122,557,731.6586,950,138.5858,040,447.95
归属于母公司股东的综合收益总额31,212,181.59122,557,731.6586,950,138.5858,040,447.95
公告日期2025-04-262025-03-282024-10-182024-08-28
审计意见(境内)标准无保留意见
TOP↑